Statin drugs can delay prostate cancer progression in patients receiving androgen deprivation therapy, study shows

Thursday, May 7, 2015 - 12:00 in Health & Medicine

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial shows.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net